1. Wang SM, Guan CF. The effects of cordyceps sinensis on Interleukin-2 secretion. Chinese Journal of Experimental & Clinical Immunology 1990;2:40-42.
2. Guan CF, Wang LC, Xie YZ, Xu SL, Zhang YX, Wang SM, Jin J, Wang YZ. Immunological alternation in weakness syndrome modeled in donkey and rat. Chinese Journal of Veterinary Medicine 1990;3:40-42.
3. Sperisen P, Wang SM, Reichenbach P, Nabholz M. A PCR-based assay for reporter gene expression. PCR Methods and Applications 1992;1:164-170.
4. Sperisen P, Wang SM, Bucher P, Corthesy P, Reichbach P, Nabholz M. The Biphasic Transcriptional Response of the IL2R Gene to IL1 and IL2 reflects bipartotie structure of the 5′ flanking region. Journal of Biological Chemistry 1995;270(18):10743-10753.
5. Nabholz M, Soldani E, Sperisen P, Pla M, Wang SM, MacDonald HR, Reichenbach P, Beermann F, Bucher P. The Cis-acting elements controlling mouse IL2R transcription. Immunology 1995;193: 259-262.
6. Wang SM, Rowley JD. A Strategy for Gene Identification: Integrated Procedure for Gene Identification. Proc. Natl. Acad. Sci. USA 1998;95:11909-11914.
7. Wang SM, Khandekar J, Kaul K, Winchester D, Morimoto R. A method for the quantitative analysis of human heat shock gene expression using a multiplex RT-PCR assay. Cell Stress and Chaperones 1999;4:77-82.
8. Chen J, Rowley JD, Wang SM. Generation of longer cDNA fragments from serial analysis of gene expression tags for gene identification. Proc. Natl. Acad. Sci. USA 2000;97: 349-353.
9. Wang SM, Fears SC, Zhang L, Chen J-J, Rowley JD. Screening poly dA/dT(-) cDNAs for gene identification. Proc. Natl. Acad. Sci. USA 2000;97:4162-4167.
10. Yang X, Ferguson AT, Nass SJ, Kim P, Butash A, Wang SM, Herman JG, Davidson NE. Transcriptional activation of estrogen receptor in human breast cancer cells by histone deacetylase inhibition. Cancer Res. 2000;60:6890-6894.
11. Lee S, Chen J, Zhou G, Wang SM. Generation of high quantity and quality tag/ditag cDNAs for SAGE analysis. BioTechniques 2001;31:348-354.
12. Lee S, Zhou G, Clark T, Chen J, Rowley JD, Wang SM. The pattern of gene expression in human CD15+ myeloid progenitor cells. Proc. Natl. Acad. Sci. USA 2001;98:3340-3345.
13. Chen J, Rowley D, Clark T, Lee S, Zhou G, Cheers C, Rowley JD, Wang SM. Genome-level identification of expressed genes in mouse Gr-1+ myeloid progenitor cells. Genomics 2001;77:149-162.
14. Zhou G, Chen J, Lee S, Clark T, Rowley JD, Wang SM. The pattern of gene expression in human CD34+ hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 2001;98:13966-13971.
15. Chen J, Lee S, Zhou G, Wang SM. High-throughput GLGI procedure for converting a large number of serial analysis of gene expression tag sequences into 3’ complementary DNAs. Genes, Chromosomes & Cancer 2002;33:252-261.
16. Lee S, Clark T, Chen J, Zhou G, Scott LR, Rowley JD, Wang SM. Correct identification of genes from SAGE tag sequences. Genomics 2002;79:598-599.
17. Nam D, Lee S, Zhou G, Cao X, Wang C, Chen J, Clark T, Rowley JD, Wang SM. Oligo dT primer generates a high frequency of truncated cDNAs through internal poly A priming during reverse transcription. Proc. Natl. Acad. Sci. USA. 2002;99:6152-6156.
18. Clark T, Lee S, Scott LR, Wang SM. Computational analysis of gene identification with SAGE. Journal of Computational Biology 2002;3:513-526.
19. Müschen M, Lee S, Zhou G, Feldhahn N, Barath VS, Chen J, Moers C, Krönke M, Rowley JD, Wang SM. Molecular portraits of B cell lineage commitment. Proc. Natl. Acad. Sci. USA 2002;99:10014-10019.
20. Chen J, Sun M, Lee S, Zhou G, Rowley JD, Wang SM. Identifying novel transcripts and novel genes in the human genome by using novel SAGE tags. Proc. Natl. Acad. Sci. USA 2002;99:12257-12262.
21. Wang SM. The new role of SAGE in gene discovery. Trends in Biotechnology 2003;21:57-58.
22. Sun M, Zhou G, Lee S, Chen J, Shi RZ, Rowley JD, Wang SM. SAGE is far more sensitive than EST for detecting low abundant transcripts. BMC Genomics 2004;5:1-4.
23. Silva A, Chen J, Carraro DM, Wang SM, Camargo AA. Convert Massive Parallel Signature Sequencing Tags into 3’ cDNA. Nucleic Acid Research 2004;32:e94.
24. Lee S, Bao J, Zhou G, Shapino J, Xu J, Shi RZ, Lu X, Clark T, Johnson D, Kim YC, Wing C, Tseng C, Sun M, Lin W, Wang J, Du W, Wu CI, Zhang X, Wang SM. Detecting novel low-abundant transcripts in Drosophila. RNA 2005;11:939-946.
25. Bao J, Lee S, Chen C, Zhang XQ, Zhang Y, Liu SQ, Clark T, Wang J, Cao ML, Yang HM, Wang SM, J Yu. SAGE (Serial Analysis of Gene Expression) Study of a Hybrid Rice Strain (LYP9) and Its Parental Cultivars. Plant Physiology, 2005;138:1216-1231.
26. Ge X, Yamamoto S, Tsutsumi S, Midorikawa Y, Ihara S, Wang SM, H Aburatani. Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics, 2005;86:127-141.
27. Lee S, Johnson D, Dunbar K, Dong H, Ge X, Kim YC, Wing C, Jayathilaka N, Emmanue N, Zhou CQ, Gerber HL, Tseng CC, Wang SM. 2.45 GHz Radiofrequency fields alter gene expression in cultured human cells. FEBS Letters 2005;579:4829-4836.
28. Kang HS, Kim EM, Lee S, Yoon SR, Kawamura T, Lee YC, Kim S, Myung PK, Wang SM, Choi I. Stage-dependent gene expression profiles during natural killer cell development. Genomics 2005;86:551-65.
29. Ge X, Jung YC, Wu Q, Kibbe WA, Wang SM. Annotating non-specific SAGE tags with microarray data. Genomics 2006;87:173-180.
30. Lee S, Chen J, Zhou G, Shi RZ, Bouffard G, Kocherginsky M, Ge X, Sun M, Jayathilaka N, Kim YC, Emmanuel N, Bohlander S, Minden M, Kline J, Ozer O, Larson R, LeBeau M, Green E, Trent J, Karrison T, Liu P, Wang SM, Rowley JD. Gene Expression Profiles in Acute Myeloid Leukemia with Common Translocations using SAGE. Proc. Natl. Acad. Sci. USA 2006;103:1030-1035.
31. Wang SM. Applying the SAGE technique to study the effects of electromagnetic field on biological systems. Proteomics. 2006;6:4765-4768.
32. Ge X, Wu Q, Jung YC, Chen J, Wang SM. A large quantity of novel human antisense transcripts detected by LongSAGE. Bioinformatics. 2006;22:2475-2479.
33. Gerber HL, Bassi A, Khalid, Zhou C, Wang SM, Tseng CC. Analytical and Experimental Dosimetry of a T-25 Flask in a thermally controlled waveguide. IEEE Transactions on Plasma Science 2006;34:1449-1454.
34. Ge X, Wu Q, Wang SM. SAGE detects microRNA precursors. BMC Genomics 2006;7:285-287.
35. Kim YC, Jung Y-C, Xuan Z, Zhang MQ, Wang SM. Pan-genome isolation of low abundant transcripts through SAGE tag mis-priming. FEBS Letters 2006;580:6721–6729.
36. Wu QQ, Tommerup N, Wang SM, Hansen L. A novel primate specific gene, CEI, is located in the homeobox gene IRXA2 promoter in Homo sapiens. Gene 2006;371:167-73.
37. Lee S, Hwang J, Ulaszek J, Kim YC, Dong H, Kim HS, Seok JW, Suh BK, Yim SJ, Johnson D, Choe NH, Chang KT, Ryoo ZY, Tseng CC, Wickrema A, Wang SM. Stable transcriptional status in the apoptotic erythroid genome. Biochem Biophys Res Commun. 2007;359:556-562.
38. Wang SM. Understanding SAGE data. Trends in Genetics 2007;23:42-50.
39. Lu J, Shen Y, Wu Q, Kumar S, He B, Carthew RW, Wang SM, Wu CI. The birth and death of microRNA genes in Drosophila. Nature Genetics 2008;40:351-355.
40. Chen J, Kim YC., Jung Y-C, Xuan Z, Dworkin G, Zhang Y, Zhang MQ, Wang SM. Scanning the human genome at kilobase resolution. Genome Research 2008;18:751-762.
41. Wang SM. Long-short-long games in transcript identification: the length matters. Current Pharmaceutical Biotechnology, 2008;9:362-367.
42. Wu Q, Kim YC, Lu J, Xuan Z, Chen J, Zheng YL, Zhou T, Zhang MQ, Wu CI, Wang SM. Poly A- transcripts expressed in HeLa cells. PLoS ONE 2008;3:e2803.
43. Li Z, Luo RT, Mi S, Sun M, Chen P, Bao J, Neilly MB, Jayathilaka N, Johnson DS, Wang L, Lavau C, Zhang Y, Tseng C, Zhang X, Wang J, Yu J, Yang H, Wang SM, Rowley JD, Chen J, Thirman MJ. Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. Cancer Res. 2009;69:1109-1116.
44. Kim YC., Wu Q, Chen J, Xuan Z, Jung Y-C, Zhang MQ, Rowley JD, Wang SM. The transcriptome of human CD34+ hematopoietic stem-progenitor cells. Proc. Natl. Acad. Sci. USA 2009;106:8278-8283.
45. Jung YC, Xu J, Chen J, Kim YC, Winchester DJ, Wang SM. Simplified DGS procedure for large-scale genome structural study. BioTechniques 2009;47:969-971.
46. Lu J, Shen Y, Carthew RW, Wang SM, Wu CI. Reply to “A conservative assessment of microRNA flux in Drosophila. Nature Genetics. 2010;42:9-10.
47. Wang SM, Zhang MQ. The progress and challenge for transcriptome study on human CD34+ hematopoietic stem-progenitor cells. Journal of Cellular Physiology J Cell Physiol. 2010;223:549-552.
48. Huang X, Guo H, Tammana S, Jung YC, Mellgren E, Bassi P, Ma L, Tu ZJ, Ekker SC, Wu X, Wang SM, Zhou XZ. Gene Transfer Efficiency and Genome-Wide Integration Profiling of Sleeping Beauty, Tol2 and PiggyBac Transposons in Human Primary T Cells. Molecular Therapy. 2010;18(10):1803-13.
49. Kim YC., Jung YC, Chen J, Alhasan AH, kaewsaard P, Zhang Y, Wu CI, Ma S, Rosen S, Wang SM. Evidence for widely presence of genomic aberrations in chronic lymphocytic leukemia. BMC Research Notes. 2010;3:341.
50. Xu J, Wang D, Zhang C, Song J, Liang T, Kim YC, Jin WR, Wang SM, Hou GH. The alternatively expressed genes identified in the CD4+ T cells of skin allograft rejection mice Cell. Transplantation. 2011;20:333-50.
51. H, Li Y, Malek SN, Kim YC, Xu J, Chen P, Xiao F, Huang X, Zhou X, Xuan Z, Mankala S, Hou G, Rowley JD, Zhang MQ, Wang SM. New fusion transcripts identified in normal karyotype acute myeloid leukemia. PLoS One. 2012;7:e51203.
52. Gong Q, Tao T, Yang J, Cai J, Yuan Y, Ruan J, Yang J, Lu X, Zhuang S, Wang SM, Wu CI. Identification of medium-sized genomic deletions with low coverage, mate-paired restricted tags. BMC Genomics. 2013;14:51.
53. Ling M, Ban L, Wen H, Wang SM, Ge SX. Conserved Expression of Natural Antisense Transcripts in Mammals. BMC Genomics. 2013;14:243.
54. Lynch H, Wen H, Kim YC, Snyder C, Kinarsky Y, Chen PX, Xiao F, Goldgar D, Cowan KH, Wang SM. Can unknown predisposition in familial breast cancer be family-specific? The Breast Journal. 2013;19:520-528.
55. Xiao F, Kim YC, Wen H, Luo J, Chen P, Cowan K, Wang SM. The genome of polymorphonuclear neutrophils maintains normal coding sequences. PLOSOne. 2013;8:e78685.
56. COMPLEXO, Southey MC, Park DJ, Nguyen-Dumont T, Campbell I, Thompson E, Trainer AH, Chenevix-Trench G, Simard J, Dumont M, Soucy P, Thomassen M, Jønson L, Pedersen IS, Hansen TV, Nevanlinna H, Khan S, Sinilnikova O, Mazoyer S, Lesueur F, Damiola F, Schmutzler R, Meindl A, Hahnen E, Dufault MR, Chris Chan T, Kwong A, Barkardóttir R, Radice P, Peterlongo P, Devilee P, Hilbers F, Benitez J, Kvist A, Törngren T, Easton D, Hunter D, Lindstrom S, Kraft P, Zheng W, Gao YT, Long J, Ramus S, Feng BJ, Weitzel JN, Nathanson K, Offit K, Joseph V, Robson M, Schrader K, Wang SM, Kim YC, Lynch H, Snyder C, Tavtigian S, Neuhausen S, Couch FJ, Goldgar DE. COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration. Breast Cancer Res. 2013;15:402.
57. Xiao F, Kim YC, Snyder C, Wen H, Chen PX, Luo J, Becirovic D, Downs B, Cowan KH, Lynch H, Wang SM. Genome instability in blood cells of a BRCA1+ breast cancer family. BMC Cancer. 2014;14:342.
58. Wen H, Kim Y, Snyder C, Xiao F, Fleissner EA, Becirovic D, Luo J, Downs B, Sherman S, Cowan KH, Lynch HT, Wang SM. Family-specific, novel, deleterious germline variants provide a rich source to identify genetic predispositions for BRCAx familial breast cancer. BMC Cancer. 2014;14:470.
59. Lynch H, Synder C, Wang SM. Considerations for comprehensive assessment of genetic predisposition in familial breast cancer. Breast J. 2015;21:67-75.
60. Downs B, Wang SM. Epigenetic changes in BRCA1-mutated familial breast cancer. Cancer Genetics, 2015;208:237-40.
61. Downs B, Kim YC, Xiao F, Snyder C, Chen P, Fleissner EA, Becirovic D, Wen H, Sherman S, Cowan KH, Lynch HT, Wang SM. Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer. Breast Cancer Res Treat. 2015;151:219-24.
62. Angulo-Ibáñez M, Rovira-Clavé X, Downs B, Kim YC Wang SM, Tournier C, Reina M, Espel E. Erk5 contributes to balance cellular nucleotide levels and avoid replicative stress. Cell Cycle. 2015;14:3864-76.
63. Kim YC, Zhao L, Zhang H, Huang Y, Cui J, Xiao F, Downs B, Wang SM. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients. Oncotarget. 2016 Feb 23;7(8):9600-12. doi: 10.18632/oncotarget.7144. PMID: 26848529; PMCID: PMC4891063.
64. Cui J, Luo L, KimYC, Synder C, Becirovic D, Downs B, Lynch H, Wang SM. Differences of variable number tandem repeats in XRCC5 promoter are associated with increased or decreased risk of familial breast cancer. Frontiers in Oncology. 2016;6:00092.
65. Kim YC, Cui J, Luo J, Xiao F, Downs B, Wang SM. Exome-based Variant Detection in Core Promoters. Sci Rep. 2016;6:30716.
66. Downs B, Xiao F, Kim YC, Chen PX, Huang D, Fleissner EA, Cowan K, Wang SM. Single-base LOH can be used as specific marker to classifyBRCAx familial breast cancer into more homogenous subtypes. The Breast Journal. 2016;23:479-481.
67. Kim YC, Soliman AS, Cui J, Ramadan M, Hablas A, Abouelhoda M, Hussien N, Ahmed O, Zekri AN, Seifeldin IA, Wang SM. Unique features of germline variation in five Egyptian Familial Breast Cancer families revealed by exome sequencing. PLOS One. 2016;12:e0167581.
68. Wang SM. Pros and cons for population screening BRCA mutation carriers. Clinics in Oncology. 2016;1:1161.
69. Chen P, Kim YC, Akhtari M, Wang SM. An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/ Acute Myeloid Leukemia. Int J Cancer Res Mol Mech. 2017;3(2):2381-3318.
70. Liao W, Liu H, Zhang Y, Jung JH, Chen J, Su X, Kim YC, Flores ER, Wang SM, Czarny-Ratajczak M, Li W, Zeng SX, Lu H. Ccdc3: A new p63 target involved in regulation of liver lipid metabolism. Sci Rep. 2017;7:9020.
71.Downs B, Sherman S, Cui J, Kim YC, Snyder C, Christensen M, Luo J, Lynch H, Wang SM. Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers. Eur J Cancer. 2019 Jan;107:68-78.
72. Bhaskaran SP, Chandratre K, Gupta H, Zhang L, Wang X, Cui J, Kim YC, Sinha S, Jiang L, Lu B, Wu X, Qin Z, Huang T, Wang SM. Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients. Int J Cancer. 2019 Aug 15;145(4):962-973.
73. Guo M, Sinha S, Wang SM. Coupled Genome-Wide DNA Methylation and Transcription Analysis Identified Rich Biomarkers and Drug Targets in Triple-Negative Breast Cancer. Cancers (Basel). 2019 Nov 4;11(11):1724.
74. Zhang L, Bhaskaran SP, Huang T, Dong H, Chandratre K, Wu X, Qin Z, Wang X, Cao W, Chen T, Lynch H, Wang SM. Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature. Eur J Cancer. 2020 Jan;125:12-21.
(https://genemutation.fhs.um.edu.mo/dbmmr-chinese/,doi: 10.1136/jmedgenet-2021-107886)
75. Sinha S, Wang SM. Classification of VUS and unclassified variants in BRCA1 BRCT repeats by molecular dynamics simulation. Comput Struct Biotechnol J. 2020 Mar 21;18:723-736.
76. Dong H, Chandratre K, Qin Y, Zhang J, Tian X, Rong C, Wang N, Guo M, Zhao G, Wang SM. Prevalence of BRCA1/BRCA2 pathogenic variation in Chinese Han population. J Med Genet. 2020 May 28:jmedgenet-2020-106970.
77. Qin Z, Kuok CN, Dong H, Jiang L, Zhang L, Guo M, Leong HK, Wang L, Meng G, Wang SM. Can population BRCA screening be applied in non-Ashkenazi Jewish populations? Experience in Macau population. J Med Genet. 2020 Aug 17:jmedgenet-2020-107181. doi: 10.1136/jmedgenet-2020-107181.
(https://genemutation.fhs.um.edu.mo/dbbrca-macau/,doi: 10.1136/jmedgenet-2020-107181)
78. Bhaskaran SP, Huang T, Rajendran BK, Guo M, Luo J, Qin Z, Zhao B, Chian J, Li S, Wang SM. Ethnic-specific BRCA1/2 variation within Asia population: evidence from over 78 000 cancer and 40 000 non-cancer cases of Indian Chinese Korean and Japanese populations. J Med Genet. 2020. doi: 10.1136/jmedgenet-2020-107299.
(https://genemutation.fhs.um.edu.mo/dbbrca-chinese/)
(https://genemutation.fhs.um.edu.mo/dbbrca-indian/)
(https://genemutation.fhs.um.edu.mo/dbbrca-korean/)
(https://genemutation.fhs.um.edu.mo/dbbrca-japanese/)
doi: 10.1136/jmedgenet-2020-107299
79. Gupta H, Chandratre K, Sinha S, Huang T, Wu X, Cui J, Zhang MQ, Wang SM. Highly diversified core promoters in the human genome and their effects on gene expression and disease predisposition. BMC Genomics. 2020 Nov 30;21(1):842. doi: 10.1186/s12864-020-07222-5. PMID: 33256598; PMCID: PMC7706239.
(https://genemutation.fhs.um.edu.mo/dbhcpd/,doi: 10.1186/s12864-020-07222-5)
80. Tam B, Sinha S, Wang SM. Combining Ramachandran plot and molecular dynamics simulation for structural-based variant classification: Using TP53 variants as model. Comput Struct Biotechnol J. 2020 Dec 2;18:4033-4039. doi: 10.1016/j.csbj.2020.11.041. PMID: 33363700; PMCID: PMC7744649.
81. Sinha, S. and S. M. Wang (2020). “Classification of VUS and unclassified variants in BRCA1 BRCT repeats by molecular dynamics simulation.” Comput Struct Biotechnol J 18: 723-736.
82. Hu, D., Z. Lian, H. Xian, R. Jiang, N. Wang, Y. Weng, X. Peng, S. Wang and X. K. Ouyang (2020). “Adsorption of Pb(II) from aqueous solution by polyacrylic acid grafted magnetic chitosan nanocomposite.” Int J Biol Macromol 154: 1537-1547.
83. Zhang, L., Z. Qin, T. Huang, B. Tam, Y. Ruan, M. Guo, X. Wu, J. Li, B. Zhao, J. S. Chian, X. Wang, L. Wang and S. M. Wang (2021). “Prevalence and spectrum of DNA mismatch repair gene variation in the general Chinese population.” J Med Genet.
84. Jiang, R., H. Huang, Z. Lian, Z. Hu, R. S. Lloyd, D. Fang, Y. Li, H. Xian, J. Yuan, Y. Sha, S. Wang and D. Hu (2020). “Exosomal miR-221 derived from hydroquinone-transformed malignant human bronchial epithelial cells is involved in cell viability of recipient cells.” J Appl Toxicol 40(2): 224-233.
85. Lian, Z., Z. Hu, H. Xian, R. Jiang, H. Huang, Y. Jiang, Z. Zheng, R. S. Lloyd, J. Yuan, Y. Sha, S. Wang and D. Hu (2020). “Exosomes derived from normal human bronchial epithelial cells down-regulate proliferation and migration of hydroquinone-transformed malignant recipient cells via up-regulating PTEN expression.” Chemosphere 244: 125496.
86. Wang X, Wang SM. DNA damage repair system in C57BL/6 J mice is evolutionarily stable. BMC Genomics. 2021 Sep 17;22(1):669. doi: 10.1186/s12864-021-07983-7. PMID: 34535077; PMCID: PMC8447752.
87. Guo M, Wang SM. Genome Instability-Derived Genes Are Novel Prognostic Biomarkers for Triple-Negative Breast Cancer. Front Cell Dev Biol. 2021 Jul 12;9:701073. doi: 10.3389/fcell.2021.701073. PMID: 34322487; PMCID: PMC8312551.
88. Chian J, Sinha S, Qin Z, Wang SM. BRCA1 and BRCA2 Variation in Taiwanese General Population and the Cancer Cohort. Front Mol Biosci. 2021 Jun 21;8:685174. doi: 10.3389/fmolb.2021.685174. PMID: 34235180; PMCID: PMC8256441.
(https://genemutation.fhs.um.edu.mo/dbbrca-taiwan/,doi: 10.3389/fmolb.2021.685174)
89. Tam B, Sinha S, Qin Z, Wang SM. Comprehensive Identification of Deleterious TP53 Missense VUS Variants Based on Their Impact on TP53 Structural Stability. Int J Mol Sci. 2021 Oct 20;22(21):11345. doi: 10.3390/ijms222111345. PMID: 34768775; PMCID: PMC8583684.
90. Sinha S, Tam B, Wang SM. RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor. Viruses. 2021 Dec 21;14(1):1. doi: 10.3390/v14010001. PMID: 35062205; PMCID: PMC8781274.
91. Li J, Zhao B, Huang T, Qin Z, Wang SM. Human BRCA pathogenic variants were originated during recent human history. Life Sci Alliance. 2022 Feb 14;5(5):e202101263. doi: 10.26508/lsa.202101263. PMID: 35165121; PMCID: PMC8860097.
92. Huang T, Li J, Wang SM. Core promoter mutation contributes to abnormal gene expression in bladder cancer. BMC Cancer. 2022 Jan 15;22(1):68. doi: 10.1186/s12885-022-09178-z. PMID: 35033028; PMCID: PMC8761283.
93. Sinha S, Qin Z, Tam B, Wang SM. Identification of deleterious variants of uncertain significance in BRCA2 BRC4 repeat through molecular dynamics simulations. Brief Funct Genomics. 2022 Mar 22:elac003. doi: 10.1093/bfgp/elac003. Epub ahead of print. PMID: 35325018.
94. Qin Z, Huang T, Guo M, Wang SM. Distinct landscapes of deleterious variants in DNA damage repair system in ethnic human populations. Life Sci Alliance. 2022 May 20;5(9):e202101319. doi: 10.26508/lsa.202101319. PMID: 35595529; PMCID: PMC9122833.
(https://genemutation.fhs.um.edu.mo/dbddr-global/,doi: 10.26508/lsa.202101319)
95. Wu X, Guo M, Cui J, Cai H, Wang SM. Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage. Oncogenesis. 2022 Jul 22;11(1):41. doi: 10.1038/s41389-022-00417-3. PMID: 35869059; PMCID: PMC9307611.
96. Qin Z, Li J, Tam B, Sinha S, Zhao B, Bhaskaran SP, Huang T, Wu X, Chian JS, Guo M, Kou SH, Lei H, Zhang L, Wang X, Lagniton PNP, Xiao F, Jiang X, Wang SM. Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population. Int J Cancer. 2022 Nov 17. doi: 10.1002/ijc.34359. Epub ahead of print. PMID: 36385461.
(https://genemutation.fhs.um.edu.mo/Asian-BRCA/,doi: 10.1002/ijc.34359)
97. Guo M, Wang SM. The BRCAness Landscape of Cancer. Cells. 2022 Dec 1;11(23):3877. doi: 10.3390/cells11233877. PMID: 36497135; PMCID: PMC9738094.
98. San Ming Wang,
A global perspective on the ethnic-specific BRCA variation and its implication in clinical application, Journal of the National Cancer Center, 2022, ISSN 2667-0054, https://doi.org/10.1016/j.jncc.2022.12.001.
99. Tam B, Qin Z, Zhao B, Wang SM, Lei CL. Integration of deep learning with Ramachandran plot molecular dynamics simulation for genetic variant classification. iScience. 2023 Feb 2;26(3):106122. doi: 10.1016/j.isci.2023.106122. PMID: 36879825; PMCID: PMC9984559.